A dispute over protection measures for Australia’s endangered koalas yesterday threatened to topple the government of the country’s biggest state.
Angered by a new koala conservation law, the rural-based National Party withdrew its support for New South Wales Premier Gladys Berejiklian’s governing Liberal Party, saying that the law comes at the expense of farmers.
The move left Berejiklian with a minority government, unable to pass legislation.
The dispute comes months after bushfires destroyed vast swathes of koala habitat, prompting fears for the species’ survival.
In a coalition with the Nationals, Berejiklian’s Liberals have governed the state that runs from populous coastal areas that include Sydney to a rural outback.
In a statement, the Nationals decried the koala bill as “a blunt instrument to make city-centric law makers feel good about themselves,” claiming it prevents farmers from clearing their own land.
Environmental groups criticized the stance, saying koalas might be on track for extinction in the state by 2050.
“Wanting to retain the right to kill koalas is an extraordinary hill for the Nationals to want to die on, but here we are,” Nature Conservation Council chief executive Chris Gambian said.
Corey Bradshaw, a professor of global ecology at Flinders University, said the legislation was “a mere band-aid in the fight to stem further deforestation.”
New South Wales has some of the weakest anti-land clearing laws in Australia, he said, adding that poor enforcement and low penalties exacerbate the problem.
“With increasing mega bushfires, the legacy and persistence of broad-scale deforestation, and weak laws, koalas in New South Wales are effectively doomed,” he said. “Koalas live in and eat trees — you don’t need a university degree to predict what will happen.”
Berejiklian gave National members of the state Cabinet until this morning to decide whether they wished to stay in her Cabinet or quit the coalition.
Additional reporting by Reuters.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very
RSS